Close Menu

NEW YORK, Feb 27 – Illumina of San Diego said Tuesday it had penned a deal with Chevron Research and Technology to study ways Illumina’s fiber-optic BeadArray microarray technology could be used to detect compounds in chemical plant operations.

Chevron, which is funding the study, expects to complete the research by early 2002. Chevron previously invested in Illumina through its venture capital group.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

New analyses indicate female researchers are publishing less during the coronavirus pandemic than male researchers, according to Nature News.

A study suggests people with the ApoE e4 genotype may be more likely to have severe COVID-19 than those with other genotypes, the Guardian says.

Direct-to-consumer genetic testing companies are searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.

In PNAS this week: forward genetics-base analysis of retinal development, interactions of T cell receptors with neoantigens in colorectal cancer, and more.